Daily Hong Kong Stock Market News Express (Friday, September 20)

Individual Stock News

1. Sino-Ocean Group Real Estate (06158.HK): The final deadline for the restructuring support agreement has been further extended.

2. China Railway Signal & Communication Corporation Limited (03969.HK): In July and August, it won six important projects in the rail transit market, with a total bid amount of approximately 2.9 billion yuan, accounting for about 7.84% of the audited operating income in 2023.

3. Jinyang New Energy (01121.HK): Its subsidiary has entered into a joint venture agreement with JN Energy and Longi, planning to establish a joint venture company to produce HBC solar cells.

4. Ocuvite Biotech B (01477.HK): The new drug OT-1001 approved by the National Medical Products Administration has been granted market registration.

5. China Biotech Services (08037.HK): It plans to cooperate with Jinshazhou Hospital of Guangzhou University of Chinese Medicine in the areas of boron neutron capture therapy drugs and medical devices, referral cooperation, equity cooperation, and indication expansion.

6. Fosun Pharma (01652.HK): The clinical trial application for the innovative traditional Chinese medicine "SY617" in Category 1 has been approved.

7. New China Textbook (00811.HK): Signed a 1.256 billion yuan procurement contract to become the sole source supplier of textbooks for compulsory education stage students in Sichuan Province.

8. Sunshine Insurance (06963.HK): Sunshine Life Insurance's premium income from January to August reached 66.384 billion yuan